Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-10,000
Closed -$2.46M – 42
2023
Q3
$2.46M Sell
10,000
-10,000
-50% -$2.52M 1.24% 32
2023
Q2
$5M Buy
20,000
+5,000
+33% +$1.06M 1.17% 28
2023
Q1
$3.2M Hold
15,000
– – 1.38% 34
2022
Q4
$2.91M Buy
+15,000
New +$2.97M 1.37% 31
2014
Q4
– Sell
-45,000
Closed -$2.58M – 69
2014
Q3
$2.58M Sell
45,000
-15,000
-25% -$772K 1.17% 41
2014
Q2
$2.83M Buy
60,000
+35,000
+140% +$1.51M 1.43% 31
2014
Q1
$1.19M Buy
+25,000
New +$1.11M 0.74% 59

Other funds holding ICLR

Sivik Global Healthcare's ICLR Position: Q4 2023 in Review

Sivik Global Healthcare sold out of Icon (ICLR) in Q4 2023, closing a stake of 10,000 shares — an estimated $2.46M sold.

Sivik Global Healthcare first reported a position in ICLR in Q1 2014 and held it in 7 quarters. The position peaked at $5M in Q2 2023. 600 funds tracked by Wall St. Rank hold ICLR as of Q4 2023.

  • Sivik Global Healthcare reported no remaining Icon position as of Q4 2023 after selling out during the quarter.
  • Sivik Global Healthcare sold 10,000 Icon shares in Q4 2023, an estimated $2.46M.
  • Sivik Global Healthcare first reported a position in Icon in Q1 2014 and held it in 7 quarters.
  • Sivik Global Healthcare's Icon position peaked at $5M in Q2 2023.
  • 600 funds tracked by Wall St. Rank held Icon as of Q4 2023.

Based on Sivik Global Healthcare's 13F filing for Q4 2023, filed 5 Feb 2024.